NCT00077714View on ClinicalTrials.gov

Trial Evaluating the Efficacy and Safety of 2 Fixed Doses of Paliperidone Extended-Release (ER) Tablets in the Treatment of Adult Patients With Schizophrenia

PHASE3CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

January 31, 2004

Study Completion Date

January 31, 2005

Conditions
Schizophrenia
Interventions
DRUG

Paliperidone ER

All Listed Sponsors
lead

Johnson & Johnson Pharmaceutical Research & Development, L.L.C.

INDUSTRY

NCT00077714 - Trial Evaluating the Efficacy and Safety of 2 Fixed Doses of Paliperidone Extended-Release (ER) Tablets in the Treatment of Adult Patients With Schizophrenia | Biotech Hunter | Biotech Hunter